基于中医古籍文献的升降散应用溯源及探析

通过对中医古籍中有关升降散论述的文献梳理,全面探讨其内涵。本方是在大黄、僵蚕为雏形的基础上增加蝉蜕、姜黄而成方,几经易名,终在杨璿《伤寒瘟疫条辨》中为后人所熟知。本方广泛用于治疗瘟疫,以丸剂、散剂为主,方便携带,便于服用;重用大黄旨在祛邪、逐秽;应用时视人之体质强弱和量其毒之轻重而判断用药多寡,并辅以米酒、生蜜等以顾护正气。杨璿将其由治疗“热疫”的专方扩展为治疗“表里三焦大热”的通用方剂,扩大了本方治疗疾病范围。     

高渗盐水和甘露醇在动脉瘤性蛛网膜下腔出血患者降低颅内压中的应用

目的比较3%高渗盐水和20%甘露醇治疗重症动脉瘤性蛛网膜下腔出血所致颅内压增高的疗效.方法25例动脉瘤性蛛网膜下腔出血患者出现颅内压增高事件时, 随机交替接受等渗透剂量的160 mL 3%高渗盐水与150 mL 20%甘露醇进行降低颅内压治疗, 连续监测患者颅内压、平均动脉压、脑灌注压及中心静脉压.记录有效降低颅内压持续时间、颅内压最大降幅及其时间, 用药前及用药后1 h、3 h血钠水平及血浆渗透压.结果3%高渗盐水和20%甘露醇均可降低颅内压(均 P < 0.01), 两者的降低颅内压作用持续时间及颅内压降幅差异均无统计学意义(均 P >0.05).患者脑灌注压较用药前均上升(均 P < 0.01), 平均动脉压先上升后下降, 但差异无统计学意义( P >0.05).患者中心静脉压稍有波动, 但差异均无统计学意义(均 P >0.05).20%甘露醇治疗后患者血钠下降, 3%高渗盐水治疗后患者血钠值上升, 变化均有统计学意义(均 P < 0.05).20%甘露醇及3%高渗盐水治疗后患者血浆渗透压均先上升后下降, 变化均有统计学意义(均 P < 0.01). 结论3%高渗盐水可作为治疗动脉瘤性蛛网膜下腔出血所致颅内压增高患者的一线治疗药物.     

批准用于奶牛的抗菌药物分析

我国奶牛养殖规模不断扩大,奶业产值比重逐步提高,给奶牛疫病防治带来巨大压力。奶牛乳房炎及细菌性肺炎等呼吸系统疾病和细菌性肠炎等消化系统疾病最为常见,抗菌药物的使用成为主要防治手段。但抗菌药物的不当使用易使细菌产生耐药性,增加临床治疗的成本和难度,危害我国奶牛产业发展。本文对截至2021年7月我国和美国、英国、日本、欧盟批准用于奶牛的抗菌药物产品进行整理、统计与分析,包括抗菌药物的分类、剂型以及适应证等,旨在为我国奶牛用抗菌药物管理、合理用药和新兽药开发提供参考。     

A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery

The inflammatory response induced by cardiopulmonary bypass decreases vascular tone, which in turn can lead to vasoplegic syndrome. Indeed the hypotension consequent to on-pump cardiac surgery often necessitates vasopressor and intravenous fluid support. Methylene blue counteracts vasoplegic syndrome by inhibiting the formation of nitric oxide.We report the use of methylene blue in a 75-year-old man who developed vasoplegic syndrome after cardiac surgery. After the administration of methylene blue, his hypotension improved to the extent that he could be weaned from vasopressors. The use of methylene blue should be considered in patients who develop hypotension refractory to standard treatment after cardiac surgery.     

Avanzando en la sistematización del benchmarking en servicios de salud pública

Continuous management improvement should be an aspiration for all public sector organizations. External comparison or benchmarking identifies good practices in similar organizations. For public health services, it is not easy to obtain such indicators. The objectives of this paper are to describe the process of conducting a benchmarking exercise for a public health agency, and to share its results. For this purpose, agencies that may be compared were identified, and their websites were searched for annual reports or other documents with indicators of the activities or results of public health services. Limitations and contextual aspects of the indicators of the different organizations were identified, as well as ways to improve their comparability. Finally, a set of 19 indicators is proposed, as an initial core for quality management comparisons.     

经鼻给予抗ICAM-1抗体对大鼠脑缺血再灌注损伤的保护作用

目的 探讨经鼻腔给予抗细胞间黏附分子-1(ICAM-1)单克隆抗体(单抗)对大鼠脑缺血再灌注损伤的保护作用.方法 将30只雄性Wistar大鼠随机分为假手术组、脑缺血再灌注组及脑缺血再灌注+经鼻给予高、中、低剂量抗ICAM-1单抗干预组.采用插线法制作局灶脑缺血再灌注模型.各干预组于缺血1 h经鼻给予抗ICAM-1单抗,再灌24 h后取脑行冠状切片.采用TTC、HE及免疫组化染色法测定脑梗死体积及免疫组化阳性区占总面积比.结果 缺血再灌注组脑标本均可见缺血侧的脑膜充血,脑组织肿胀;单纯脑缺血再灌注组及低、中、高抗ICAM-1单抗干预组脑梗死体积(以像素值表示)分别为57 042±12 483、32 871±4 325、25 932±3 103和15 325±3 356,免疫组化阳性区面积占总面积比分别为(6.64±0.476)%、(5.15±0.987)%、(4.36±0.682)%和(3.42±0.537)%,各组间差异均有统计学意义.结论 (1)脑缺血再灌注可使脑组织ICAM-1表达显著增高;(2)经鼻腔给予抗ICAM-1单抗可有效降低脑组织ICAM-1的表达,缩小脑梗死体积;(3)经鼻腔给予抗ICAM-1单抗的剂量同脑梗死体积呈负相关;(4)脑缺血再灌注时ICAM-1免疫组化阳性区面积比与脑梗死体积呈正相关.     

医院常用消毒剂使用管理及效益对比

通过对医院消毒剂使用现状调查,为其合理使用提供依据,采用问卷填表的方法,对集团所属 77个临床科室及部门常规使用的消毒剂种类、配制、剂量、费用和存在问题等进行调查。结果,各临床科室及部门常规消毒剂使用率为 100%;使用合理率为 46. 8%,使用不合理率为 53. 2%。每月常规消毒使用费用为 30 767. 4元,规范消毒剂使用后测算每月费用可降低 47% ~71. 8%。结论,通过计划发放,消毒剂合理选择,规范消毒剂配制、用量和使用方法,可减少损耗,降低成本。